Elevated serum insulin is an independent risk factor for hepatocellular carcinoma: A case control study from Nepal

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7331-7333

  Gupta, Satrudhan Pd ^a   Mittal, Ankush ^a   Sathian, Brijesh ^b   Jha, Dipendra Kumar ^a  

^a Nepalese Army Institute of Health Sciences   (Nepal)

^b MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

Glucose; HCC risk; Insulin; Nepal; Serum levels

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ANALYSIS; BLOOD; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; COMPARATIVE STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEPAL; PATHOLOGY; PROGNOSIS; RISK FACTOR;

ADULT; BLOOD GLUCOSE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEPAL; PROGNOSIS; RISK FACTORS;

EID: 84893401411     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7331     Document Type: Article

References (13)

1. Chong RJ, Abdullah MS, Hossain MM, et al (2013). Rising incidence of primary liver cancer in brunei darussalam. Asian Pac J Cancer Prev, 14, 3473-7.
2. Chao LT, Wu CF, Sung FY, et al (2011). Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort. Carcinogenesis. 32, 876-81.
3. Hsu CS, Liu CJ, Liu CH, et al (2008). High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int, 28, 271-7.
4. Henley KS, Pollard HM (1955). A new method for the determination of glutamic oxalacetic and glutamic pyruvic transaminase in plasma. J Lab Clin Med, 46, 785.
5. Hsiao PJ, Chen ZC, Hung WW, et al (2013). Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver. BMC Med Genet, 14, 54.
6. Jha DK, Mittal A, Gupta SP, et al (2012). Association of type II diabetes mellitus with hepatocellular carcinoma occurrence-a case control study from Kathmandu Valley. Asian Pac J Cancer Prev,13, 5097-9.
7. Kahn CR, Rosenthal AS (1979). Immunologic reactions to insulin, insulin allergy, insulin resistance and autoimmune insulin syndrome. Diabetes Care, 2, 283-95.
8. Mastracci TL, Sussel L (2012). The endocrine pancreas: insights into development, differentiation, and diabetes. Wiley Interdiscip Rev Dev Biol,1, 609-28.
9. Morss AS, Edelman ER (2007). Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem, 282, 14635-44.
10. Paradis V, Perlemuter G, Bonvoust F, et al (2001). High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatol, 43,738-44.
11. Ren YQ, Han JQ, Cao JB, et al (2012). Association of MDR1 gene polymorphisms with susceptibility to hepatocellular carcinoma in the Chinese population. Asian Pac J Cancer Prev, 13, 5451-4.
12. Richardson LC, Pollack LA (2005). Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol, 2, 48-53.
13. Trinder P (1969). Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem, 6, 24-7.